Impact of ubiquitous blood pressure monitoring
Joint Event on 3rd International Conference on Medical Sciences, Hypertension and Healthcare and World Congress on Organ Transplantation and Artificial Organs
August 24-25, 2018 Tokyo, Japan

Chris Elliott

Leman Micro Devices SA, Switzerland

Scientific Tracks Abstracts: Health Care Current Reviews

Abstract:

For many patients??? hypertension is asymptomatic, often called the silent killer. Early detection and treatment can massively reduce mortality but need accurate measurement. For most people that is not possible, either because they cannot visit a medical practitioner or, even if they could, their consultations are hurried and rare with little time for a proper measurement of resting BP. Emerging technologies can change this. BP measurement using sensors and software built in to the ubiquitous smartphone can be medically accurate and free to the user. When coupled with telehealth consultations, it opens up a new vision of hypertension management. When used with other sensors already in the smartphone, the diagnosis extends to cardiac volume, arrhythmias, single-lead ECG and heart valve timing. The author???s company is conducting clinical trials of a device that is small enough and cheap enough to be bundled with every smartphone, so opening up the prospect of 1 billion people per year gaining this capability at no direct cost, just as the camera in the phone imposes no direct cost. All of the measurements meet accepted accuracy standards because they use mature techniques like Riva-Rocci but with no cuff for blood pressure, infrared detection for body temperature, pulse oximetry for blood oxygen and others. The device is already in quantity production and is expected to be widely available in 2019. LMD???s sensor delivers actionable and reliable data to the user and clinician and has the potential to change hypertension management globally.

Biography :

Chris Elliott is a Fellow of the UK Royal Academy of Engineering and a Barrister (trial lawyer) specializing in regulated technology. He has wide experience of the development of leading-edge technological products and their regulatory approval. For the last 7 years, he has specialized in the innovative measurement of blood pressure and the clinical exploitation of the results.

E-mail: cje@leman-micro.com